Thomas E. Kraft
Impact in
- Aging top 10%
- Genetics, Aging, and Longevity in Model Organisms
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Glycosylation and Glycoproteins Research 2
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Paul W. Hruz (8 shared papers)Monique R. Heitmeier (4 shared papers)Thomas Efferth (1 shared paper)Jan R. Crowley (2 shared papers)Cassandra B. Higgins (2 shared papers)Brian J. DeBosch (2 shared papers)Allyson L. Mayer (2 shared papers)Kevin E. Yarasheski (2 shared papers)
- Journals
- Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)mAbs (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Thomas E. Kraft
21 papers receiving 626 citations
Peers
Comparison fields: 5 of 105
- Aging 37
- Geriatrics and Gerontology 56
- Physiology 30
- Epidemiology 202
- Molecular Biology 258
Countries citing papers authored by Thomas E. Kraft
This map shows the geographic impact of Thomas E. Kraft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Kraft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Kraft more than expected).
Fields of papers citing papers by Thomas E. Kraft
This network shows the impact of papers produced by Thomas E. Kraft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Kraft. The network helps show where Thomas E. Kraft may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Kraft, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 225 | |
| 2 | 2009 | 100 | |
| 3 | 2016 | 89 | |
| 4 | 2016 | 52 | |
| 5 | 2019 | 47 | |
| 6 | 2017 | 22 | |
| 7 | 2015 | 21 | |
| 8 | 2016 | 16 | |
| 9 | 2014 | 16 | |
| 10 | 2015 | 15 | |
| 11 | 2010 | 10 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 5 | |
| 15 | Outcomes of recent efforts at rice university to incorporate entrepreneurship concepts into interdisciplinary capstone design | 2012 | 4 |
| 16 | 2024 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 1991 | 2 | |
| 19 | 2002 | 2 | |
| 20 | Electric Vehicles--A Historical Snapshot. | 2012 | 1 |
About Thomas E. Kraft
Thomas E. Kraft is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Surgery, Immunology and Infectious Diseases, having authored 21 papers that have together received 647 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Pancreatic function and diabetes (4 papers), Metabolism, Diabetes, and Cancer (3 papers), CAR-T cell therapy research (2 papers), Glycosylation and Glycoproteins Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Malaria Research and Control (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Aging (37 citations), Geriatrics and Gerontology (56 citations), Physiology (30 citations), Epidemiology (202 citations) and Molecular Biology (258 citations). Thomas E. Kraft has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Paul W. Hruz, Monique R. Heitmeier, Thomas Efferth, Jan R. Crowley, Cassandra B. Higgins, Brian J. DeBosch, Allyson L. Mayer, Kevin E. Yarasheski, Richard C. Hresko and Nicholas O. Davidson. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, Antimicrobial Agents and Chemotherapy, mAbs and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.